In Unity Lies Power; Building a Better Bioanalytical World Together
YSS Final Program
for a downloadble PDF version of the presentation click here
| 08:30 | 08:35 | Welcome and Introduction |
| 08:35 | 10:15 | session 1: Overcoming Bioanalytical Mysteries |
| 08:35 | 08:55 | Farjana Mahammed (GlaxoSmithKline) |
| Analytical Method Transfer – Are our methods Smooth Sailing or Slowly Sinking? | ||
| 08:55 | 09:15 | Patrick Heath (Covance) |
| Overcoming soluble target interference in an Immunogenicty screening assay incorporating an immunodepletion step using streptavidin magnetic beads. | ||
| 09:15 | 09:35 | Stacey Casswell (Envigo) |
| Challenges and considerations in the use of a immunoassay method for the detection of TSH, T3 and T4 for use in reproduction/developmental toxcology studies. | ||
| 09:35 | 09:55 | Jana Zemenová (University of Prague) |
| Lipopeptides – challenges in bioanalysis of novel pharmaceutical targets via LC-MS and immunomethods | ||
| 09:55 | 10:15 | Jason Pembroke (LGC) |
| Bioanalytical Challenges of Chelating Compound | ||
| 10:15 | 10:45 | Coffee break |
| 10:45 | 12:15 | Project YSS: Together we succeed: feedback from YSS collaboration |
| projects | ||
| 10:45 | 11:30 | Feedback from the pre-competitive collaborative work between |
| AstraZeneca, Charles River, Covance, GlaxoSmithKline, Ghent University, Janssen R&D LGC and Q2-solutions on Liquid Microsampling | ||
| Moderators: Aline Swinnen and Sheelan Ahmad (for EBF-YSS) | ||
| 11:30 | 12:15 | Feedback from the pre-competitive collaborative work between |
| AstraZeneca, Charles River, LGC MedImmune and Novimmune SA on multiplex biomarker assay performance | ||
| Moderators: Jonathan Paraskos and Sufyan Maqbool (for EBF-YSS) | ||
| 12:15 | 13:15 | Lunch break |
| 13:15 | 14:55 | Session 2: Transforming Bioanalysis Through Innovation |
| 13:15 | 13:35 | Mikko Hölttä (AstraZeneca) |
| Bioanalytical strategies for quantification of intact RNA and its metabolites | ||
| 13:35 | 13:55 | Sofie Velghe (University of Ghent) |
| Fully automated direct extraction and analysis of dried blood spots for the determination of five anti-epileptic drugs and one active metabolite | ||
| 13:55 | 14:15 | Yannick Van Wanseele (Free University of Brussels) |
| The application of superchargers to increase nanoUHPLC-MS/MS method sensitivity for quantification of the neuropeptide neuromedin U | ||
| 14:15 | 14:35 | Emily Bell (Charles River) |
| Immunocapture as a Viable Sample Preparation Technology in the Transition between Pre-Clinical and Clinical Bioanalysis | ||
| 14:35 | 14:55 | Kees Pelster (PRA Health Sciences) |
| Validation of capillary microsampling assays: a practical point of view | ||
| 14:55 | 15:15 | Tea break |
| 15:15 | 17:00 | Session 3: Ask The Experts |
| 15:15 | 15:35 | Morgan Evans (Intertek) |
| Technologies of Immunogenicity: An ADA case study | ||
| 15:35 | 15:55 | Sijranke Post (PRA Health Sciences) |
| The challenges in validating a 6-color T-, B- and NK-cell flow cytometry assay in human whole blood using multiple blood collections tubes as well as manual and automatic sample processing. | ||
| 15:55 | 16:15 | Adeline Besson (Novimmune SA) |
| Development and validation of a novel biomarker assay to support the development of a biologic | ||
| 16:15 | 16:35 | Godknows Hlatshwayo (LGC) |
| Case Study: Immunoassay Development for a gene therapy drug | ||
| 16:35 | 16:55 | Sara Capiau (University of Ghent) |
| Development and validation of an ICP-MS method to quantitatively determine cobalt in volumetric absorptive microsampling (VAMS) devices for the follow-up of metal-on-metal prosthesis patients. | ||
| 16:55 | 17:00 | 2016 Best Presenter prize and Wrap-up |
| 17:00 | 17:00 | Adjourn |
Copyright 2023 EBF
EBF vzw is the registered non-profit organisation of the European Bioanalysis Forum
Read more about EBF at our community site: www.e-b-f.eu